Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the nidus of Aβ plaques develops from within neurites at a time course that could also fit that of plaque formation determined by multiphoton microscopy (MPM) occurring within a day [120].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the AD brain, microglia accumulate at the site of newly formed A deposits via migration or local proliferation and may help restrict plaque growth.4,5”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brains of AD patients and APP-overexpressing mice, plaques are surrounded by reactive microglia and astrocytes (Meyer-Luehmann et al., 2008; Serrano-Pozo et al., 2013)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Meyer-Luehmann et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia appear rapidly (within one day) at the site of newly formed plaques [78].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“Remarkably, this MPM study of AD transgenic mouse brain in vivo also described the emergence of dystrophic neurites in areas distant from plaques that appeared and, at times, even disappeared, although intraneuronal Aβ was not examined in these neurites.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [120]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · cited 2×
“These data thus lead to a model consistent with a prediction of the amyloid hypothesis in which amyloid deposition, activation and recruitment of microglia and local neuritic changes play out as a sequential cascade leading to neurodegeneration 1 .”
BackgroundResultWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“It is possible that submicroscopic nuclei may be present in the cortex 23 , perhaps related to the recently reported amyloid-β oligomeric forms 24,25 , as precursors to this sudden growth.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“To examine whether the phenotype of plaque formation in as short a period as one week was unique to the aggressive APP/PS1 transgenic mouse model, we used a mouse line that has a slower progression of disease (Tg2576) 7 .”
BackgroundMethodImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“In addition, homozygous PDAPP mice 16 were crossed with homozygous CX3CR1-GFP mice 17 , and two female PDAPP +/ − ×CX3CR1-GFP +/ − transgenic mice at the age of 18 months were used in this study and imaged for three consecutive days.”
BackgroundMethodJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178 · cited 1×
“These results are surprising because it has been generally accepted, based on in vitro studies of protein aggregation, that amyloid-β aggregation is time dependent and follows a relatively slow nucleation-dependent polymerization process 22 .”
ResultJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 1×
“It has been proposed that activated microglia clear amyloid deposits 13 , are the nidus for initiation of amyloid fibrils 14 or restrict plaques 15 .”
Background
Cited by
Items 501–600 of 995
Lysosomal Functions in Glia Associated with Neurodegeneration
Kreher, C., Favret, J., Maulik, M., & Shin, D. (2021) · Biomolecules · doi:10.3390/biom11030400 · Cited by 38
“Further, extracellular Aβ precedes neuronal degeneration and prompts a swift microglial response [130].”
BackgroundQuality Control Compartments Coming of Age
Ben‐Gedalya, T., & Cohen, E. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01330.x · Cited by 40
Shimojo, M., Higuchi, M., Suhara, T., & Sahara, N. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00482 · Cited by 39
Early Effects of Aβ Oligomers on Dendritic Spine Dynamics and Arborization in Hippocampal Neurons
Ortiz-Sanz, C., Gaminde-Blasco, A., Valero, J., Bakota, L., Brandt, R., Zugaza, J. L., Matute, C., & Alberdi, E. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00002 · Cited by 38
“In vivo studies in AD mouse models revealed that Aβ deposits have a direct toxic effect on neurites, including dendritic simplification, loss of dendritic spines, and neuritic dystrophies (Spires et al., 2005; Meyer-Luehmann et al., 2008).”
BackgroundAnimal Models for Alzheimer’s Disease and Frontotemporal Dementia: A Perspective
Götz, J., & Götz, N. N. (2009) · ASN Neuro · doi:10.1042/an20090042 · Cited by 38
“Multiphoton imaging has also been used to determine that plaque formation in mice can be a surprisingly rapid process, with an Ab plaque forming within 24 h (Meyer-Luehmann et al., 2008).”
MethodScheffler, K., Stenzel, J., Krohn, M., Lange, C., Hofrichter, J., Schumacher, T., Bruning, T., Plath, A.-S., Walker, L., & Pahnke, J. (2011) · Current Alzheimer Research · doi:10.2174/156720511797633179 · Cited by 37
“In addition to the most prevalent pathologic characteristics such as β-amyloid (Aβ) plaques, neurofibrillary tangles, and cerebrovascular amyloidosis, many studies provide evidence of inflammatory changes that occur during the pathogenesis of AD, particularly involving microglia [2,3].”
BackgroundKajiwara, Y., McKenzie, A. T., Dorr, N. P., Sosa, M. A. G., Elder, G. A., Schmeidler, J., Dickstein, D. L., Bozdagi, O., Zhang, B., & Buxbaum, J. D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw265 · Cited by 45
Matsui, T., Mizuno, H., Sudo, T., Kikuta, J., Haraguchi, N., Ikeda, J.-I., Mizushima, T., Yamamoto, H., Morii, E., Mori, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07244-2 · Cited by 41
Guo, D., Yamamoto, M., Hernandez, C. M., Khodadadi, H., Baban, B., & Stranahan, A. M. (2021) · Nature Communications · doi:10.1038/s41467-021-24540-8 · Cited by 40
Potential Immunotargets for Alzheimer's Disease Treatment Strategies
Fernández, P. L., Britton, G. B., & Rao, K. S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121222 · Cited by 37
A combination Alzheimer’s therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice
Devi, L., & Ohno, M. (2015) · Molecular Brain · doi:10.1186/s13041-015-0110-5 · Cited by 40
“dence that indicates that Aβ plaques induce structural and functional disruption of neuron networks [56-60].”
BackgroundRodriguez, J. J., Noristani, H. N., Hilditch, T., Olabarria, M., Yeh, C., Witton, J., & Verkhratsky, A. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.036 · Cited by 40
Zhang, Y., Zhao, Y., Zhang, J., Gao, Y., Li, S., Chang, C., Yu, D., & Yang, G. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136206 · Cited by 36
Tondo, G., Marchi, F. D., Bonardi, F., Menegon, F., Verrini, G., Aprile, D., Anselmi, M., Mazzini, L., & Comi, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113098 · Cited by 46
“Fibrils and plaques, the last steps of A β aggregation, have been associated with neurite disruption, decreased spine density, synaptic dysfunction, and neuronal loss [38,39].”
BackgroundDifferentiation of mouse bone marrow derived stem cells toward microglia-like cells
Hinze, A., & Stolzing, A. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-35 · Cited by 41
“They migrate towards sites of injury and lesion and extracellular debris such as amyloid-b plaques [8].”
BackgroundPardon, M., Lopez, M. Y., Ding, Y., Marjańska, M., Prior, M. J. W., Brignell, C. J., Parhizkar, S., Agostini, A., Bai, L., Auer, D. P., et al. (2016) · Scientific Reports · doi:10.1038/srep19880 · Cited by 49
Xiao, A.-W., He, J., Wang, Q., Luo, Y., Sun, Y., Zhou, Y., Yang, G., Lucassen, P. J., & Dai, J. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1736-7 · Cited by 37
“[35] Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, et al.”
BackgroundMicroglia in Alzheimer's Disease: A Role for Ion Channels
Thei, L., Imm, J., Kaisis, E., Dallas, M. L., & Kerrigan, T. L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00676 · Cited by 36
Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
Almansoub, H. A. M. M., Tang, H. R., Wu, Y., Wang, D., Mahaman, Y. A. R., Wei, N., Almansob, Y. A. M., He, W., & Liu, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180868 · Cited by 43
Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Taliyan, R., Chandran, S. K., & Kakoty, V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716101411 · Cited by 35
The endocannabinoid system in neuropathological states
Martínez-Orgado, J. A., Fernández‐Ruíz, J., & Romero, J. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782828 · Cited by 40
“Remarkably, recent data suggest that the formation of these pathological structures is a rather fast event, leading to the appearance of a new plaque in less than a 24-h period with accompanying glia recruitment in 1 or 2 days (Meyer-Luehmann et al., 2008).”
BackgroundSignificant structural but not physiological changes in cortical neurons of 12-month-old Tg2576 mice
Rocher, A. B., Kinson, M. S., & Luebke, J. I. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.014 · Cited by 41
Liebscher, S., & Meyer-Luehmann, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00026 · Cited by 36
“The appearance of new plaques is a rare, but rapid event that is age-dependent (Meyer-Luehmann et al., 2008; Burgold et al., 2011; Hefendehl et al., 2011; Figures 2A,B).”
BackgroundMethodInfluentialSelf-citationKaniowska, D., Wenk, K., Rademacher, P., Weiss, R., Fabian, C., Schulz, I., Guthardt, M., Lange, F., Greiser, S., Schmidt, M., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10261-4 · Cited by 38
“Additionally, activated microglia are commonly associated with amyloid – β (Aβ) containing plaques [4] which can directly stimulate Dorota Kaniowska and Kerstin Wenk share the first authorship.”
BackgroundHopkins, P. C. R., Sáinz-Fuertes, R., & Lovestone, S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-102115 · Cited by 35
Krstic, D., & Knuesel, I. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-62 · Cited by 35
“This hypothesis is well in line with the observation that Aβ plaques form over 24 hours [45], possibly as an acute reaction to a burst or leakage of an axon as suggested in [44].”
ResultAmyloid-β42 protofibrils are internalized by microglia more extensively than monomers
Gouwens, L. K., Makoni, N. J., Rogers, V. A., & Nichols, M. R. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.016 · Cited by 35
New insights in drug development for Alzheimer's disease based on microglia function
Qiao, O., Ji, H., Zhang, Y., Zhang, X., Zhang, X., Liu, N., Huang, L., Liu, C., & Gao, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111703 · Cited by 35
Zhu, J., Freitas, H. R., Maezawa, I., Jin, L., & Srinivasan, V. J. (2021) · Light Science & Applications · doi:10.1038/s41377-021-00586-7 · Cited by 39
Early β‐amyloid accumulation in the brain is associated with peripheral T cell alterations
Gericke, C., Kirabali, T., Flury, R., Mallone, A., Rickenbach, C., Kulic, L., Toševski, V., Höck, C., Nitsch, R. M., Treyer, V., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13136 · Cited by 36
Monitoring in vivo function of cortical microglia
Brawek, B., & Garaschuk, O. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.02.011 · Cited by 36
Liebscher, S., Page, R., Kaefer, K., Winkler, E., Quinn, K., Goldbach, E. G., Brigham, E. F., Quincy, D. A., Basi, G. S., Schenk, D., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.122 · Cited by 37
Self-citationNeuroimmune Biomarkers in Mental Illness
Herron, J. W., Nerurkar, L., & Cavanagh, J. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_45 · Cited by 37
Yu, Y., Yin, T., Peng, Q., Kong, L., Li, C., Tang, D., & Yin, X. (2019) · ACS Sensors · doi:10.1021/acssensors.8b01493 · Cited by 35
Lv, G., Shen, Y., Zheng, W., Yang, J., Li, C., & Lin, J. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900054 · Cited by 35
Asher, D. M., Belay, E. D., Bigio, E. H., Brandner, S., Brubaker, S. A., Caughey, B. W., Clark, B., Damon, I. K., Diamond, M. I., Freund, M. P., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa109 · Cited by 35
“In vitro, it readily fibrillizes, and in vivo, in mouse experiments, plaques can be seen to nucleate and grow quite quickly (15).”
BackgroundSelf-citationOptical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
Luo, Z., Xu, H., Liu, L., Ohulchanskyy, T. Y., & Qu, J. (2021) · Biosensors · doi:10.3390/bios11080255 · Cited by 38
“[79] developed a novel in vivo multiphoton imaging method and observed Aβ plaques and amyloid angiopathy by methoxy-X04 and thS, which was consistent with previous results obtained by Bacskai et al.”
BackgroundResultKarlnoski, R. A., Rosenthal, A., Kobayashi, D., Pons, J., Alamed, J., Mercer, M., Li, Q., Gordon, M. N., Gottschall, P. E., & Morgan, D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4560-08.2009 · Cited by 34
“(2008) studied the kinetics of plaque formation using a multiphoton laser confocal microscope, and discovered that new plaques form within 24 h and their size and final characteristics stabilize within a week (Meyer-Luehmann et al., 2008).”
BackgroundBeta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer’s Disease
Korsak, M., & Kozyreva, T. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20164-1_14 · Cited by 38
Neuropathology of Alzheimer's Disease and its Variants
Duyckaerts, C., & Dickson, D. (2011) · Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders · doi:10.1002/9781444341256.ch10 · Cited by 34
PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies
Shojaei, M., Schaefer, R., Schlepckow, K., Kunze, L. H., Struebing, F. L., Brunner, B., Willem, M., Bartos, L. M., Feiten, A., Palumbo, G., et al. (2024) · Theranostics · doi:10.7150/thno.97149 · Cited by 36
Immunotherapy for Alzheimer’s disease
Solomon, B., & Frenkel, D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.004 · Cited by 37
Ferrera, D., Mazzaro, N., Canale, C., & Gasparini, L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.023 · Cited by 37
Ni, J., Xie, Z., Quan, Z., Meng, J., & Qing, H. (2023) · Glia · doi:10.1002/glia.24465 · Cited by 34
“As soon as A β plaques form in the brain, microglia establish intimate contact with them and become reactive (Meyer-Luehmann et al., 2008; Prinz et al., 2019).”
BackgroundTau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses
Rudinskiy, N., Hawkes, J. M., Wegmann, S., Kuchibhotla, K. V., Muzikansky, A., Betensky, R. A., Spires-Jones, T. L., & Hyman, B. T. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-63 · Cited by 32
“Then, methoxy-X04 (5 mg/kg) [44] diluted in Texas Red dextran solution (12.”
MethodSelf-citationNeural circuit changes in neurological disorders: Evidence from in vivo two-photon imaging
Xiong, H., Tang, F., Guo, Y., Xu, R., & Peng, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101933 · Cited by 36
Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
Toyn, J. H., & Ahlijanian, M. K. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt244 · Cited by 39
“microenvironments [89] and perturb mitochondrial”
Lettiero, B., Andersen, A. J., Hunter, A. C., & Moghimi, S. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.036 · Cited by 35
Ramberg, V., Tracy, L. M., Samuelsson, M., Nilsson, L. N. G., & Iverfeldt, K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-34 · Cited by 37
Murakami, K., & Irie, K. (2019) · Molecules · doi:10.3390/molecules24112125 · Cited by 31
Hadipour, M., Meftahi, G. H., Afarinesh, M. R., Jahromi, G. P., & Hatef, B. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101837 · Cited by 35
Wang, X., Yu, H. Q., Wang, C., Liu, Y., You, J., Wang, P., Xu, G., Shen, H., Yao, H., Lan, X., et al. (2020) · Toxicology · doi:10.1016/j.tox.2020.152625 · Cited by 31
The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
Shen, Y., Qian, L., Luo, H., Li, X., Ruan, Y., Fan, R., Si, Z., Chen, Y.-P., Li, L., & Liu, Y. (2022) · Brain Sciences · doi:10.3390/brainsci12081057 · Cited by 35
The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia
Mishra, S., Morshed, N., Sidhu, S. B., Kinoshita, C., Stevens, B., Jayadev, S., & Young, J. E. (2025) · Glia · doi:10.1002/glia.70009 · Cited by 31
Wu, L., Cao, T., Li, S., Yuan, Y., Zhang, W., Huang, L., Cai, C., Fan, L., Li, L., Wang, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.980636 · Cited by 36
Ghimire, A., Rehman, S. A., Subhani, A., Khan, M. A., Rahman, Z., Iqubal, M. K., & Iqubal, A. (2025) · hLife · doi:10.1016/j.hlife.2024.11.006 · Cited by 38
“This demonstrates that older people ’ s brains have more readily activated microglia than younger brains [21].”
Arendt, T., Morawski, M., Gärtner, U., Fröhlich, N., Schulze, F., Wohmann, N., Jäger, C., Eisenlöffel, C., Gertz, H., Mueller, W. C., et al. (2016) · Brain Pathology · doi:10.1111/bpa.12442 · Cited by 29
“Still, current concepts of Aß plaque formation as a consequence of a disturbed balance between Aß-production and clearance (106) as well as previous descriptions on a link between plaque formation and vascularization (9, 12, 74) concur with this observation.”
ResultWang, X., Wang, C., Geng, C.-H., & Zhao, K. (2018) · Europe PMC (PubMed Central) · Cited by 39
Microglial carbohydrate-binding receptors for neural repair
Linnartz‐Gerlach, B., Bodea, L., & Neumann, H. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1342-7 · Cited by 32
Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer’s disease
Woodhouse, A., Shepherd, C. E., Sokolova, A., Carroll, V. L., King, A. E., Halliday, G. M., Dickson, T. C., & Vickers, J. C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0458-z · Cited by 30
“A, potentially leading to pathological changes over a relatively short period of time [23, 27, 34 , 41, 46].”
BackgroundSorting Through the Roles of Beclin 1 in Microglia and Neurodegeneration
O’Brien, C. E., & Wyss‐Coray, T. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9519-8 · Cited by 31
Repeatable target localization for long-term in vivo imaging of mice with 2-photon microscopy
Hefendehl, J. K., Milford, D., Eicke, D., Wegenast‐Braun, B. M., Calhoun, M. E., Grathwohl, S. A., Jucker, M., & Liebig, C. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.10.029 · Cited by 33
Franchi, B., & Lorenzani, S. (2016) · Journal of Nonlinear Science · doi:10.1007/s00332-016-9288-7 · Cited by 34
“Neuronal injury is rather the result of ordered Aβ self-association [9, 20, 31, 35, 39, 46].”
BackgroundRENDICONTI DEL SEMINARIO MATEMATICO 2012
Badiale, M., Andretta, A., Capietto, A., Collino, A., Dagnino, C., Pejsachowicz, J., Pellerey, F., Tilli, P., Venturino, E., Desvillettes, L., et al. (2012) · Cited by 31
Wang, Z.-J., Han, W.-N., Chai, S.-F., Li, Y., Fu, C.-J., Wang, C.-F., Cai, H.-Y., Li, X., Wang, X., Hölscher, C., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.022 · Cited by 35
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
Mook‐Jung, I., Han, S.-H., Chang, Y. J., Jung, E. S., Kim, J., & Na, D. L. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s15278 · Cited by 29
The Role of Glial Cells and Synapse Loss in Mouse Models of Alzheimer’s Disease
Ziegler-Waldkirch, S., & Meyer-Luehmann, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00473 · Cited by 21
“…that are associated with neuronal and synapse loss (Tsai et al., 2004; Spires et al., 2005), increased neurite curvature (GarciaAlloza et al., 2006; Meyer-Luehmann et al., 2008), impaired neuronal activity in dendritic segments Frontiers in Cellular Neuroscience | www.frontiersin.org 1 December…”
BackgroundSelf-citationRichter, M., Vidovic, N., Biber, K., Dolga, A., Culmsee, C., & Dodel, R. (2020) · Brain Pathology · doi:10.1111/bpa.12807 · Cited by 29
“Nevertheless, only a few studies have experimentally demonstrated the effects of microglial Aβ phagocytosis on neuronal damage (66, 84).”
BackgroundThree-dimensional real time imaging of amyloid β aggregation on living cells
Kuragano, M., Yamashita, R., Chikai, Y., Kitamura, R., & Tokuraku, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-66129-z · Cited by 31
Li, J., Zhang, Z., Deng, X., Xu, Z., Wang, L., Xu, G., Wang, K., Wang, D., & Tang, B. Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121612 · Cited by 30
Potential of food-derived bioactive peptides in alleviation and prevention of Alzheimer's disease
Zhao, L., Li, D., Qi, X., Guan, K., Chen, H., Wang, R., & Ma, Y. (2022) · Food & Function · doi:10.1039/d2fo02278h · Cited by 31
Kang, M., Hansen, T. J., Mickiewicz, M., Kaczynski, T. J., Fye, S., & Gunawardena, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104617 · Cited by 32
Repeat Mild Traumatic Brain Injury in Adolescent Rats Increases Subsequent β-Amyloid Pathogenesis
Grant, D. A., Serpa, R. O., Moattari, C. R., Brown, A., Greco, T., Prins, M. L., & Teng, E. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5042 · Cited by 33
“Likewise, accelerated deposition of Ab plaques in the rTBI24 group could activate and recruit additional microglia that further facilitate adjacent neuritic changes.(76) Although these questions were not the focus of the current study, future investigations targeting these issues will be necessary to further unravel t…”
BackgroundKoizumi, T., Taguchi, K., Mizuta, I., Toba, H., Ohigashi, M., Onishi, O., Ikoma, K., Miyata, S., Nakata, T., Tanaka, M., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1467-7 · Cited by 34
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
Qian, Z., Wang, Z., Li, B., Meng, X., Kuang, Z., Li, Y., Yang, Y., & Ye, K. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02565-x · Cited by 28
Protein phosphatase 5 protects neurons against amyloid‐β toxicity
Sanchez‐Ortiz, E., Hahm, B. K., Armstrong, D. L., & Rossie, S. S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06337.x · Cited by 29
“To better understand the neuroprotective role of PP5 against Ab toxicity, it will be important in future studies to address the role of PP5 in oligomeric Ab-induced neuronal death, as well as in mouse models of familial AD where both oligomeric and fibrillar Ab have been shown to contribute to neurodegeneration (Goate…”
BackgroundHeiss, J. K., Barrett, J., Yu, Z., Haas, L. T., Kostylev, M. A., & Strittmatter, S. M. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw188 · Cited by 28
Probing the fibrillation of lysozyme by nanoscale-infrared spectroscopy
Islam, Z., Ali, M. H. M., Popelka, A., Mall, R., Ullah, E., Ponraj, J., & Kolatkar, P. R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1734091 · Cited by 29
Glycoengineering artificial receptors for microglia to phagocytose Aβ aggregates
Yu, D., Liu, C., Zhang, H., Ren, J., & Qu, X. (2021) · Chemical Science · doi:10.1039/d0sc07067j · Cited by 29
Ren, W., Li, L., Zhang, J., Vaas, M., Klohs, J., Ripoll, J., Wolf, M., Ni, R., & Rudin, M. (2022) · Biomedical Optics Express · doi:10.1364/boe.458290 · Cited by 32
Deng, X., Xu, Z., Zhang, Z., Zhang, W., Li, J., Zheng, L., Chen, X., Pan, Y., Qiu, P. S., Wang, D., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202205151 · Cited by 28
Longitudinal in vivo two‐photon fluorescence imaging
Crowe, S. E., & Ellis‐Davies, G. C. R. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23502 · Cited by 32
“…and co-workers reported longitudinal imaging of another bigenic mouse (cross of an unspecified YFP mouse with the APPswe/PS1d9) in which the appearance of plaques was very rapid (over 1 day), but no equivalent neurite fragmentation to that reported by Gan was seen (Meyer-Luehmann et al., 2008).”
ResultAlzheimer’s Disease and Neuronal Network Activity
Gleichmann, M., & Mattson, M. P. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8100-3 · Cited by 32
“In the last decade, the Ab theory of AD subtly shifted its emphasis away from amyloid plaques which, although most likely detrimental to brain tissue (Meyer-Luehmann et al. 2008), are not necessarily regarded as the root cause of cognitive decline.”
BackgroundBedford, L., Hay, D., Paine, S., Rezvani, N., Mee, M., Lowe, J. S., & Mayer, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.009 · Cited by 35
Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
Lund, H., Pieber, M., & Harris, R. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00234 · Cited by 28
“Microglia rapidly migrate to newly formed plaques (Meyer-Luehmann et al., 2008) where they display an alteredmorphology (Frautschy et al.”
BackgroundFan, Y., Ma, Y., Huang, W., Cheng, X., Gao, N., Li, G., & Tian, S. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.02.002 · Cited by 30
Wang, H., Huang, J.-F., Li, L., Luo, J., Chen, D., Tong, J., Zeng, L., Cao, Y.-Q., Xiang, J., Luo, X.-G., et al. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.179057 · Cited by 27
“Meyer-Luehmann et al. (2008) found that Aβ plaques begin to appear in APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice at 5–6 months, and Waters et al. (2009) found BACE1 plaques in 3xTG-AD mice starting at 9 months (Waters et al., 2009; Yan et al., 2012).”
BackgroundNeurobiology of cognitive disorders
Kurz, A., & Perneczky, R. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328330588b · Cited by 32
Cai, Y., Kanyo, J. E., Wilson, R. S., Bathla, S., Cardozo, P. L., Тонг, Л., Qin, S., Fuentes, L. A., Pinheiro‐de‐Sousa, I., Huynh, T., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00823-3 · Cited by 29
“6a–d) supports the theory that spheroids form in response to extracellular amyloid deposition rather than acting as the source of these deposits 18,86 .”
Stuart, K. E., King, A. E., King, N. E., Collins, J. M., Vickers, J. C., & Ziebell, J. M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.015 · Cited by 27
Microvessel occlusions alter amyloid-beta plaque morphology in a mouse model of Alzheimer’s disease
Zhang, Y., Bander, E. D., Lee, Y., Muoser, C. A., Schaffer, C. B., & Nishimura, N. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19889092 · Cited by 29
Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity
Upadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincón-Limas, D. E., & Savas, J. N. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00654-z · Cited by 30
Stability and cytotoxicity of crystallin amyloid nanofibrils
Kaur, M., Healy, J. P., Vasudevamurthy, M. K., Lassé, M., Puškar, L., Tobin, M. J., Valéry, C., Gerrard, J. A., & Sasso, L. (2014) · Nanoscale · doi:10.1039/c4nr04624b · Cited by 26
Measuring Target Effect of Proposed Disease-Modifying Therapies in Alzheimer's Disease
Bateman, R. J., & Klunk, W. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.009 · Cited by 26
“Recent evidence has shown that plaques can form surprisingly rapidly, within 24 h, in transgenic mice and that these plaques appear to quickly stabilize in size and do not grow further.(47) This finding would seem to favor the notion that plaque formation results from a paroxysmal event, but the nature of that event i…”
BackgroundJović, M., Lončarević‐Vasiljković, N., Ivković, S., Dinić, J., Milanović, D., Zloković, B. V., & Kanazir, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216726 · Cited by 29
A research update on the potential roles of aquaporin 4 in neuroinflammation
Lan, Y., Fang, D., Zhao, J., Ma, T., & Li, S. (2015) · Acta Neurologica Belgica · doi:10.1007/s13760-015-0520-2 · Cited by 31
Alkam, T., Nitta, A., Mizoguchi, H., Itoh, A., Murai, R., Nagai, T., Yamada, K., & Nabeshima, T. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141309 · Cited by 30
“A recent study demonstrated that rapidly formed fresh amyloid plaques cause axonal and dendritic structural changes within a minimum of 5 days after the “birth of the plaques” (Meyer-Luehmann et al., 2008).”
BackgroundLana, D., Traini, C., Bulli, I., Sarti, G., Magni, G., Attorre, S., Giovannini, M. G., & Vannucchi, M. G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1451114 · Cited by 30
Entwicklung von Inhibitoren der Tau‐Aggregation bei Morbus Alzheimer
Bulic, B., Pickhardt, M., Schmidt, B., Mandelkow, E., Waldmann, H., & Mandelkow�, E. (2009) · Angewandte Chemie · doi:10.1002/ange.200802621 · Cited by 27
Is Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?
Swanton, T., Cook, J., Beswick, J. A., Freeman, S., Lawrence, C. B., & Brough, D. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218786210 · Cited by 29
Metadata
- Authors
- Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hyman, Bradley T.
- Venue
- Nature
- Published
- 2008-02
- Volume
- 451
- Issue
- 7179
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3264491
- OpenAlex
- W2107015337
- Cited by
- 987
- References
- 27
- Citations by year
- 2026: 27 · 2025: 25 · 2024: 45 · 2023: 38 · 2022: 45 · 2021: 56 · 2020: 43 · 2019: 40 · 2018: 37 · 2017: 36 · 2016: 57 · 2015: 51 · 2014: 48 · 2013: 62 · 2012: 83
- FWCI
- 66.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association
- University of Pittsburgh
- National Institutes of Health
- National Institute on Aging (R01AG008487, P50AG005134, P30AG062421)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid plaques, microglial activation, microglial recruitment, APP/PS1 mice, amyloid hypothesis, cortical degeneration
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Transgenic, Time Factors, Amyloid beta-Peptides, Neurites, Microglia, Disease Progression, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.